Autoantibodies against p53, MMP-7, and Hsp70 as Potential Biomarkers for Detection of Nonmelanoma Skin Cancers

Figure 3

Diagnostic performance of the individual autoantibodies and the autoantibody panel in the detection of skin cancer. (a) Receiver operating characteristic (ROC) curves for the ability to distinguish individuals with skin cancer from normal controls. (b) ROC curves for the ability to distinguish individuals with early-stage skin cancer from normal controls. (c) ROC curves for the ability to distinguish patients with squamous cell carcinoma from normal controls. (d) ROC curves for the ability to distinguish patients with basal cell carcinoma from normal controls.

(a)

(b)

(c)

(d)